Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Evotec Obtains E2.5m Milestone Payment From Boehringer Ingelheim
Evotec has achieved another milestone in its research collaboration with Boehringer Ingelheim. The achievement of the current milestone has led to a payment of E2.5m to Evotec, related
Evotec has achieved another milestone in its research collaboration with Boehringer Ingelheim. The achievement of the current milestone has led to a payment of E2.5m to Evotec, related
Sosei Group (Sosei) has provided updates on NVA237 and QVA149 trials. The company is planning to proceed the phase III trials with NVA237, which commenced in June 2009.
iPierian has been selected to participate in a $3.7m National Institutes of Health (NIH) Grand Opportunities (GO) grant, awarded to The Johns Hopkins University. Reportedly, the two year
ArmaGen Technologies has selected PacificGMP to produce its proprietary protein for a phase 1 clinical trial. Under the agreement, PacificGMP will use a perfusion process to produce the
Aerie Pharmaceuticals (Aerie) has reported positive results from a phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three
Sinus Dynamics has discovered treatment for Methicillin Resistant Staphylococcus Aureus (MRSA) with a nasally-inhaled aerosolized form of Vancomycin, which can help patients and hospitals limit exposure to asymptomatic
Response Biomedical has been granted a Special 510(k) US FDA clearance for an update to its RAMP Influenza A/B Assay Package Insert, to include analytical reactivity information for
Zogenix and Astellas Pharma have reported positive results from two clinical studies of new Sumavel DosePro (sumatriptan injection) needle-free delivery system – Sumavel DosePro. The new system was
EMD Chemicals (EMD), a subsidiary of Germany-based Merck, has entered into a research and commercial collaboration with MitoSciences. The new collaboration allows for co-development of multiplex immunoassay products
MedImmune has reported interim data from human studies of its nasal spray vaccine for the 2009 novel Influenza A (H1N1) virus. It demonstrated a similar clinical profile in